Wockhardt reports over six-fold jump in Q2 net profit

15 Nov 2012 Evaluate

Wockhardt has reported results for second quarter ended September 30, 2012.

The company has reported a jump of over six-fold in its net profit at Rs 345.30 crore for the quarter ended September 30, 2012 as compared to Rs 53.80 crore for the same quarter in the previous year. Total income of the company has increased by 5.45% at Rs 604.84 crore for quarter under review as compared to Rs 573.55 crore for the quarter ended September 30, 2011.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.

Wockhardt Share Price

1230.95 58.60 (5.00%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.